JYP0015

· Guangzhou JOYO Pharma Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JYP0015, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 2]